Expression Database

GUDMAP:13556
Theiler Stage TS23
Supplemental Data Files
CEL file: Tie2_E15_5_1.CEL
CHP file: Tie2_E15_5_1_rma_gene_default.chp
RPT file:
TXT file: Tie2_E15_5_1.TXT
Archive ID 206
Principal Investigator(s) Steve Potter, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA, steve.potter@cchmc.org
Submitted By Eric Brunskill, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA, brune0@cchmc.org
Specimen Details
Sample GEO ID: GSM524714
Sample Description: small blood vessels
Title: Tie2_E15.5_1
Component(s) Sampled: small blood vessels (EMAP:31470)
Organism: Mus musculus
Strain: CD-1
Genotype:
Non-wild type Allele:
Gene Tek
MGI ID MGI:3056937
MGI Symbol or lab name Tg(TIE2GFP)287Sato
Type transgenic insertion
Sex: Unknown
Development Age: 15.5 dpc
Theiler Stage: 23
Pool Size: 4-5 Embryonic Kidneys
Pooled Sample: Yes
Dissection Method: trypsinization & fluorescent activated cell sorting
Experimental Design: Tie2-GFP transgenic mice are time-mated. Pregnant Tie2-GFP transgenic mice are euthanized by standard carbon dioxide asphyxiation. All fetuses are killed by decapitation with a scalpel. Fetal kidneys are dissected from fetuses and placed in ice-cold PBS. Embryonic kidneys are incubated in the presence of 300µl of trypsin for 5 minutes at 37 ºC. Kidneys are then dissociated by titurating in the presence of 600µl of ice-cold 10%FBS/PBS. The kidneys are pelleted at 5000 rpm, 4 ºC for 5 minutes. The media is aspirates and the cell pellet is resuspended in 200µl of ice-cold 2%FBS/PBS. Filter cells through 70 micron mesh filter and proceed with FACS.
Array Hybridization
Extracted Molecule: Total RNA
A260:280 Ratio:
RNA Extraction Protocol: Potter protocol: 'RNA purification'
Target Amplification Manufacturer/kit: WT-Ovation Pico RNA Amplification System (NuGEN)
Target Amplification Protocol: Potter protocols
Rounds of Amplification: 1
Amount Labeled Target Hybridized To Array: 2.5µg
Label: Biotin
Label Protocol: The FL-Ovation cDNA Biotin Module V2 (NuGEN)
Array Hyb/Wash Protocol: Affymetrix Standard Protocol. The arrays were washed and stained using a Fluidics Station 450 (Affymetrix) utilising the fluidics protocol FS450-0007.
Scan Protocol: Probe arrays were scanned using an Affymetrix GeneChip Scanner 3000 7G and Affymetrix scanning software Genechip Operating Software Version 1.4.
GCOS Tgt Value:
Data Analysis Method: Affymetrix Expression Console and GeneSpring 10
Reference: PND 0.5 whole embryo RNA
Series Details
Series GEO ID: GSE20991
Number of Samples: 3 samples
Title: Gene expression profiles of E15.5 endothelial cells isolated from TIE2-GFP transgenic mice using FACS. (GUDMAP Series ID:38)
Summary: The long term objective is to create an encyclopedia of the expression levels of all genes in multiple components of the developing kidney. The central thesis is straightforward. The combination of fluorescent activated cell sorting (FACS) plus microarray analysis offers a powerful, efficient and effective method for the creation of a global gene expression atlas of the developing kidney. Microarrays with essentially complete genome coverage can be used to quantitate expression levels of every gene in FACS isolated components of the developing kidney. The ensuing rapid read-out provides an expression atlas that is more sensitive, more economical and more complete than would be possible by in situ hybridizations alone.
Type: Expression profiling of kidney components by microarray
Overall Design: Tie2-GFP transgenic mice were utilized to isolate the endothelial cell population from E15.5 embryonic kidneys. The endothelial cells were isolated from embryos using trypsin treatment and FACS. The RNA was isolated from purified endothelial cells and the gene expression profiles were determined by microarrays.
Platform Details
Platform GEO ID: GPL6246
Title: Affymetrix Mouse Gene 1.0 ST Array
Distribution: commercial
Technology: in situ oligonucleotide
Organism: Mus musculus
Manufacturer: Affymetrix
Manufacturer Protocol: N/A
Catalogue Number: N/A

 

Disclaimer: Please note that the development of the GUDMAP website is an on-going process. Whilst we make every effort to ensure the quality of the information on these pages, the content cannot always be guaranteed to be accurate or complete. In addition, at certain times some functions may be restricted.
Department of Health and Human Services National Institutes of Health Contacts Citing GUDMAP National Institute of Diabetes and National Institute of Child Health and Human Development